Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 10Recruiting 7Withdrawn 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 4Pancreatic Neoplasms 4Melanoma 3Lung Neoplasms 3Leukemia, Myeloid, Acute 3Colorectal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Ovarian Neoplasms 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Multiple Myeloma 2Lymphoma 2Glioblastoma 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Brain Neoplasms 2Xeroderma Pigmentosum 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Platinum-Refractory Fallopian Tube Carcinoma 1Papillomavirus Infections 1Neuroblastoma 1

Interventions

Magnetic Resonance Spectroscopy 5Temozolomide 2Immunotherapy, Adoptive 2Aminolevulinic Acid 2thymoglobulin 1temsirolimus 1poly ICLC 1pembrolizumab 1pazopanib 1orludodstat 1keyhole-limpet hemocyanin 1gallium Ga 68 dotatate 1fludarabine phosphate 1fluciclovine F-18 1dexamethasone acetate 1dexamethasone 21-phosphate 1cixutumumab 1carbon-11 acetate 1cabazitaxel 1bicalutamide 1azeliragon 1auricularum 1atezolizumab 1abemaciclib 1Valproic Acid 1Trail Making Test 1Topotecan 1Thiotepa 1Tacrolimus 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Glioma × Specimen Handling × Clear all
NCT05773664 2024-09-19

Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma

City of Hope Medical Center

Phase 1 Withdrawn
CNS

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡